Paradromics | Competitive Intelligence Profile
Paradromics is a biotechnology research company focused on developing advanced brain-computer interface (BCI) technologies aimed...
Paradromics is a biotechnology research company focused on developing advanced brain-computer interface (BCI) technologies aimed at improving brain health. Founded in 2015, the company specializes in high-resolution neural interfaces that decode brain activity to provide solutions for various medical conditions, including paralysis, chronic pain, and mental health disorders. Their flagship product, Connexus, is designed for long-term medical use and aims to help individuals with unmet medical needs.
Website
Headquarters
Austin, Texas
Size
51-200 employees
Industry
Biotechnology Research
Specialities
Neural Interfaces, Brain Computer Interface, Assistive Communication Devices, BCI, Neuroscience, Neurotechnology
🛍️ Paradromics Product and Pricing News →
👔 Paradromics CEO, Management and Leadership Team →
⚔️ Paradromics Alternatives and Competitors →
💼 Paradromics Hiring and Layoffs →
🤖 Paradromics Developer, Integration and Automation News →
📈 Paradromics Financials, Fundraising and Valuation News →
🛍️ Paradromics Product and Pricing News
- On May 14, 2025, Prof Andreas Schaefer, Co-Founder of Paradromics, will participate in a panel discussion at Jesus College, Oxford, about the science and ethics of brain-computer interfaces.
- Paradromics CEO Matt Angle hosts an informal salon with influential figures in neurotechnology.
- Matt Angle, CEO of Paradromics, discussed using brain implants to restore senses for the blind or deaf by directly inputting data from cameras or microphones.
👔 Paradromics CEO, Management and Leadership Team
⚔️ Paradromics Alternatives and Competitors
- Blackrock Neurotech |
- Kernel |
- Neuralink |
- Synchron |
- BrainCo_Tech |
- BrainGate |
- Supira Medical |
- P3 Health Partners |
- Turn Medical
💼 Paradromics Hiring and Layoffs
- Stephen Ryu has joined Paradromics as Chief Medical Officer in the United States, previously serving in the same role at another company.
- Paradromics announced Stephen Ryu, MD, as Chief Medical Officer.
🤖 Paradromics Developer, Integration and Automation News
📈 Paradromics Financials, Fundraising and Valuation News
- Leo Lion Limited has invested in Paradromics to support their development of high-bandwidth brain-computer interfaces aimed at restoring communication for people with severe neurological conditions.
People also viewed
- Synchron |
- Culture Amp |
- Langdock |
- Gallup |
- 15Five |
- Leapsome |
- People Insight
